About the Clinical Ageing Research Unit (CARU)

CARU is a £5.5 million clinical research facility funded by the Wellcome Trust and Wolfson Foundation. We opened in September 2008 and are located on the University's Campus for Ageing and Vitality.

Our primary aim is to facilitate the development of early assessment and intervention strategies targeted at age-associated degenerative conditions. Many studies are ongoing in the CARU research portfolio.

We provide a high quality, patient-friendly environment for phase II-IV clinical studies in the older patient. We employ experienced research nurses with specific training in commonly used, relevant assessment instruments. Clinical trials are supported by a high quality research infrastructure, embedded within the joint Acute Trust-University research system, with a study coordinator and data manager located on site.

Newcastle University and Newcastle upon Tyne Hospitals Foundation NHS Trust were jointly awarded Biomedical Research Centre (BRC) status by the National Institute for Health Research.

The Biomedical Research Centre in Ageing & Chronic Disease research themes comprise:

  • Dementia and Neurodegenerative Diseases
  • Stroke and Cardiovascular Ageing
  • Musculoskeletal Disease
  • Visual Failure
  • Type 2 Diabetes
  • Liver Disease
  • Mitochondrial Disease

CARU has a key role in delivering studies falling within these research themes.